INVENTIONS FOR LICENSE
MCL 1628.0: Compounds for Alcohol and Opiate Abuse
Perry Renshaw, M.D., Ph.D.
- Substance Abuse
- Treatment of Alcohol Abuse or Dependence
- Treatment of Opiate Abuse or Dependence
Background and Description
Phosphorus-31 magnetic resonance spectroscopy experiments indicate that persons who are dependent upon alcohol and opiates have decreased brain levels of phospholipids. The invention comprises the use of a class of compounds known, through studies on healthy individuals, to have activity consistent with increased phospholipid synthesis.
Potential Commercial Uses
The invention comprises a method of treating alcohol or opiate abuse or dependency, using an agent selected from a class of compounds known to cause increased phospholipid synthesis. Few, if any, effective treatments currently exist for treatment of substance abuse or dependence.
Publication and Patent Status
McLean Hospital is the owner of pending U.S. and European patent application claiming this invention.
Exclusive licenses to this technology are available in certain fields of use.
For more information, please contact:David J. Glass, Ph.D.
Senior Associate Director, Technology Transfer
McLean Hospital Research Administration
115 Mill Street
Belmont, MA 02478-9106
(617) 855-3825 - tel
(617) 855-3745 - fax